StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for early detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall in 1998 and is headquartered in Markham, Canada.
Company profile
Ticker
SZLSF
Exchange
Website
CEO
James R. Howard-Tripp
Employees
Incorporated
Location
Fiscal year end
Former names
GENENEWS LTD
SEC CIK
SZLSF stock data
Latest filings (excl ownership)
D
$3.22M in equity / options / securities to be acquired, sold $1.48M, 1 investor
17 Mar 22
D/A
$7.4M in equity / options / securities to be acquired, sold $3.29M, 6 investors
7 Feb 22
D
$7.4M in equity / options / securities to be acquired, sold $3.29M, 6 investors
4 Jan 22
D
$338.14K in equity / options / securities to be acquired, sold $198.31K, 1 investor
18 Dec 20
D
$113.45K in equity / options / securities to be acquired, sold $113.37K, 1 investor
23 Jun 20
D
$2.54M in equity / debt / options / securities to be acquired, sold $1.54M, 1 investor
22 Jun 18
D
$1.58M in equity / options / securities to be acquired, sold $852.22K, 3 investors
6 Jun 18
D
$245.56K in equity, sold $245.56K, 3 investors
31 Jul 17
D
Indefinite amount in equity, sold $370.44K, 3 investors
14 Apr 16
D
$7.21M in equity, sold $5.97M, 8 investors
22 Jul 14
Latest ownership filings
No filings
Institutional ownership, Q4 2020
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 6.00 k |
Total shares | 10.00 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Front Row Advisors | 10.00 k | $6.00 k |